Centene Leans into ACA/Marketplace
Q2 2024 Earnings
Centene reported earnings yesterday morning and they had one of their best quarters under Sarah London even in very difficult headwinds with redetermination issues. They reported 5.2% revenue growth through the first 6 months of the year and grew EPS 15% over Q2 of 2023 ($2.42 up from $2.10). The stock rallied almost 9% on Friday on the EPS growth and t…
Keep reading with a 7-day free trial
Subscribe to The Healthcare Economy to keep reading this post and get 7 days of free access to the full post archives.